The increase in price target by Goldman Sachs suggests a higher valuation for Aflac, yet the Sell rating indicates that the analyst believes the stock may still underperform the market or its sector. This mixed signal could lead to short-term volatility as investors process the implications of the new price target against the Sell recommendation.